Hyundai Bioscience Revenue

Hyundai Bioscience had revenue of 553.06M KRW in the quarter ending September 30, 2025, with 20.56% growth. This brings the company's revenue in the last twelve months to 1.96B, down -87.61% year-over-year. In the year 2024, Hyundai Bioscience had annual revenue of 15.05B with 58.73% growth.

Revenue (ttm)

1.96B

Revenue Growth

-87.61%

P/S Ratio

279.74

Revenue / Employee

28.41M

Employees

Market Cap

548.37B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	15.05B	5.57B	58.73%
Dec 31, 2023	9.48B	1.63B	20.76%
Dec 31, 2022	7.85B	-1.39B	-15.04%
Dec 31, 2021	9.24B	-3.27B	-26.14%
Dec 31, 2020	12.51B	-17.57B	-58.41%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	5.50T
Celltrion	3.90T
Yuhan	2.14T
Hanmi Pharm.	1.47T
SK Biopharmaceuticals	675.41B
Sam Chun Dang Pharm.	220.74B
ALTEOGEN	202.18B
LigaChem Biosciences	159.27B

Revenue Rankings